Tuesday 25 June 2019

Pediatric Medical Device Market SWOT Analysis By Revenue, Price & Growth Rate | Forecast To 2023

Hybrid Operating Room Market Report by Share, Size, SWOT analysis, Dynamics, Insights, Future Outlook, Demand, Profile, Trends with North America, Europe, Asia Pacific and the Middle East & Africa Regional Analysis and Key Players  NDS Surgical Imaging (US),  Mizuho OSI (US), Koninklijke Philips N.V (the Netherlands), STERIS plc. (US), Siemens Healthcare GmbH (Germany), and SISCO Ltd (India), Eschmann Equipment (UK), Cook Medical Inc. (US), General Electric Company (US), Maquet Holding BV & Co. KG (Germany), Johnson & Johnson Services, Inc. (US), Mediflex Surgical Products (US), Forecast To 2023

Hybrid Operating Room (Hybrid OR) is an advanced surgical theater that is highly equipped with futuristic medical imaging devices such as fixed C-Arms, and CT/ MRI scanners, and others so as to combine developed imaging capability with a fully functioning operating room. In Hybrid OR settings, various hybrid processes can be performed with a portable e-arm as well as optimal imaging and technical functionality. Technical advancements transpired in the healthcare domain across the globe, is acting as a key driving force to escalate Hybrid Operating Room Market growth to furthered heights.

Augmenting demand for state of the art operating rooms heading with growing demand for technologically advanced surgical process and an upsurge in the care giving facilities drive the market growth of hybrid operating room.  
Recognizing the traction the market is vibrating currently with and the potential this market holds to grow further, Market Research Future (MRFR) in its recently published study report asserts that the global Hybrid Operating Room market is expected to evaluate at exponential value by 2023, registering an impressive CAGR of 12.5% over the assessment period (2017 – 2023). 


A hybrid operating room has become an integral part of hospitals and clinical setting, providing good outcomes by improving the surgical processes. This prominence is garnering huge popularity for Hybrid OR, leading to increase its adoption. Burgeoning healthcare sector worldwide, along with the proliferation of care facilities define the growing market landscape of Hybrid OR.

Over the last decade, the healthcare industry is growing by leaps and bound due to the ever-increasing population prompting a tremendous need for effective treatment and care.  Besides a large number of market players providing technologies and equipment required in a Hybrid OR fosters the market growth across the globe. Simultaneously, the availability of advanced solutions that are enhancing the performance of healthcare professionals and caregiving facilities with improved surgical processes contributes to the market growth.

On the other hand, the high cost required for the initial set-up, installations and maintenance of a hybrid OR is expected to act as a headwind, impeding the market growth. However, the efficacy that an efficient hybrid OR provides is expected to support the market growth during the assessment period.


Global Hybrid Operating Room Market   - Segments

MRFR has segmented its analysis into four key dynamics for enhanced understanding.
By Techniques        : Fluoroscopy and Data Acquisition, Rotational Angiography, and Digital Subtraction Angiography among others.
By Applications     : Cardiovascular Surgery, Neurosurgery, Thoracic Surgery, and Endo-Bronchial Procedures among others.
By End-Users          : Hospitals, Clinics, and Medical Research Firms, among others.
By Regions              :  Europe, North America, APAC and the Rest-of-the-World.

Global Hybrid Operating Room Market – Geographical Analysis

Globally, the North American region is dominating the global Hybrid OS market owing to substantial investments transpired into R&D activities in healthcare. The well-developed economy of this region is fostering the market growth. Besides, the presence of many key players is positively impacting the market growth in the region.
Besides, some factors such as increasing number of surgeries, rising popularity of hybrid operating room, growing digital advancements in medical technology, and extensive uptake of Hybrid OS in the hospital and clinical settings are propelling the market growth in the region. 

The European region is another lucrative market for hybrid operating room standing at the second position. The market is heading with the augmenting demand for Hybrid OR in clinical settings. Undoubtedly, the resurging economy in the region is a dominant factor substantiating the market growth, increasing healthcare facilities.  Also, the increased funding in the rising numbers of specialty services offered by various health care providers provides impetus to the market growth in the region.

The hybrid OR market in the Asia Pacific region is rapidly emerging as a promising market.  Burgeoning healthcare sector along with the increasing prevalence of chronic diseases and increasing number of surgeries defines the market landscape in the region. Furthermore, rapidly improving economic conditions along with the market penetration of healthcare technology in the region provide impetus to the market growth in the APAC. Additionally, the hybrid OR market in the APAC with some of its untapped regions offers high growth opportunities.

Global Hybrid Operating Room Market   - Competitive Landscape

Highly competitive hybrid operating room market appears to be fragmented owing to the presence of several big & small market players along with new entrants churning the competition. Key players are adopting the strategic trends for business expansion in the emerging markets. Key market players are focusing on optimized situational awareness for customers, ensuring their mission success. Matured players, through various strategies such as collaboration, M&A activities, and innovations are continually seeking market expansion.

They increasingly invest in R&D activities and to develop cost-effective product portfolio. These players possess state of the art facilities to develop products and strong sales and distribution network which have helped them to gain the leadership position in the market. Marketers operating in the market are focusing on inbound lead generation more than ever.  Industry’s marketing executives look for ROI-oriented strategies that can pay off quickly. 
              
For More Details Please Visit @ Market Research Future
at No comments:

Obesity Treatment Market Segmentation | Dynamics and Share | Forecast To 2023

Obesity Treatment Market Research by SWOT Analysis, Share, Size, Segmentation, Applications, Insights,  Future Outlook, Demand, Profile, Trends with North America, Europe, Asia Pacific and the Middle East & Africa Regional Analysis and Key Players Cousin Biotech (France), EnteroMedics, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Medtronic (U.S.), USGI Medical, Inc. (U.S.), Mediflex Surgical Products (U.S.), Covidien plc (Republic of Ireland), Olympus Corporation (Japan), VIVUS, Inc. (U.S.), Arena Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), Novo Nordisk A/S (Denmark), Orexigen Therapeutics, Inc. (U.S.), Allergan (Republic of Ireland), Forecast To 2023

The global Obesity Treatment Market is expected to grow at an approximate CAGR of 16.7% during the forecast period. Growing obese population, increasing acceptance of bariatric surgeries, increasing demand for minimally invasive surgeries, and favorable reimbursement policies are expected to boost the market growth during the forecast period. However, factors such as high cost of surgery followed by the risks of infection and anesthesia allergy and low healthcare expenditure in the middle and low- income countries are estimated to restrain the market growth during the forecast period.

Segmentation

The global obesity treatment market is segmented on the basis of type, diagnosis, treatment, and end-user. On the basis of types, the market is segmented into inactivity obesity, food obesity, anxiety obesity, venous obesity, atherogenic obesity, and gluten obesity. On the basis of diagnosis, the market is categorized into blood tests, physical examination, and others. The blood tests segment is sub-segmented into cholesterol test, liver function test, thyroid test, and others.  The physical examination segment is sub-segmented into heart rate measurement, blood pressure measurement, and others. On the basis of treatment, the market is segmented into medication, surgery, lifestyle changes, and others. The medication segment is sub-segmented into orlistat, lorcaserin, phentermine and topiramate, liraglutide, and others. The surgery segment is sub-segmented into gastric bypass surgery, Laparoscopic Adjustable Gastric Banding (LAGB), gastric sleeve, biliopancreatic diversion, gastric sleeve, and others. On the basis of end-users, the market is segmented into hospitals, clinics, pharmacies, and others.


Regional Analysis

The Americas dominates the global obesity treatment market. The increasing obese population, the presence of a well-developed healthcare sector, and presence of developed economies such as the U.S. and Canada are the drivers for the market growth within the region. Additionally, increasing healthcare expenditures and presence of market players such as Medtronic, Mediflex Surgical Products, Johnson & Johnson Services, Inc., and others within the Americas boost the regional growth of the market. Europe is second in the global obesity treatment market owing to the availability of funds for research, growing obese population, and increasing adoption of bariatric surgeries within the region. 


Asia Pacific is estimated to be the fastest growing region. This can be attributed to the increasing obese population, presence of developing economies, and a growing healthcare sector within the region.  On the other hand, the Middle East and Africa holds the least share in the global obesity treatment market. The presence of poor economies and stringent government policies especially within the Africa region restrict the regional market growth.

For More Details Please Visit @ Market Research Future
at No comments:

Anti Epilepsy Drugs Market Share, Size, Growth and Dynamics | Forecast To 2022

 Anti Epilepsy Drugs Market Report by Emerging Trends, Future Outlook,  SWOT Analysis, Share, Size, Segmentation, Applications, Insights with Middle East & Africa, North America, Europe, Asia Pacific Regional Analysis and Key Players Sanofi, Shire Pharmaceuticals Limited and Cephalon Inc, Pfizer, Inc., Johnson & Johnson, UCB Pharma Ltd., Abbott, GlaxoSmithKline plc, Novartis AG, Forecast To 2022

Epilepsy is a chronic disorder that causes unprovoked and recurrent seizures. Epilepsy is the fourth most common neurological disorder and affects people of all ages. The patients are reported to loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Increasing prevalence of the epilepsy, rising per capita healthcare expenditure and increasing R&D for the therapeutic procedures of the disease drives the Anti Epilepsy Drugs Market growth during the forecast period, 2017-2022.

According to the World Health Organization in 2017, approximately 50 million people across the globe have epilepsy, making it one of the most common neurological diseases globally. Moreover, it was estimated that nearly 80% of the people with epilepsy live in low- and middle-income countries. Additionally, approval of several late-stage pipeline molecules, advancements in drugs modification and favourable government initiative fuels the market growth. However, side effects related to the therapeutic drugs, increasing generic competition and patent expirations are some of the restrains that for the growth during the forecast period.

The global anti-epilepsy drugs market is growing with the sound pace. According to a recent study report published by the Market Research Future, The global anti-epilepsy drugs market is booming and expected to gain prominence over the forecast period growing rapidly .The market is forecasted to demonstrate a sound growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022).


Global Anti-Epilepsy Drugs Market - Competitive Analysis

Characterized by the presence of several well-established and small players, the global anti-epilepsy drugs market appears to be highly competitive and fragmented. International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Pfizer Inc. is one of the major players of the global anti-epilepsy drugs market and is headquartered in the U.S. In 2015, the company’s total revenue was about USD 48,851 million and it reached USD 52,824 million in 2016. Such a significant increase in the global sales, enabled the company to invest a huge percentage of their sales into the research and development. In 2016, the company spent 14.9% of its total revenue into the R&D enabling it to improve its product portfolio and launch new product, strengthening its position in the market.


Global Anti-epilepsy Drugs Market - Regional Analysis

On the regional backgrounds the Americas leads the global market for anti-epilepsy drugs owing to a well-developed healthcare sector, increasing prevalence of epilepsy and presence of the developed technologies within the region. According to the Centres for Disease Control and Prevention, in 2015, 1.2% of the total U.S. population had active epilepsy. Moreover, it was estimated that the yearly total direct and indirect cost of epilepsy in the U.S. was about USD 15.5 billion. Europe is second in the market due to rising healthcare expenditures, huge patient population and growing healthcare R&D expenses by the government.

The Asia Pacific region is the fastest growing region due to the developing economies like India and China which are increasing their healthcare expenditures and have huge patient population. Moreover, favourable government policies within the region fuels the market growth. Middle East and Africa have the least market share, especially due to the presence of poor economies and stringent government policies within the African region.

For More Details Please Visit @ Market Research Future
at No comments:

Hybrid Operating Room Market Insights | Emerging Trends & Demand | Forecast To 2023

19 June 2019 - Pediatric Medical Device Market analysis by  Share, Size, Emerging Trends, Future Outlook,  SWOT Analysis, Applications, Insights with North America, Europe, Asia Pacific, Middle East & Africa Regional Analysis and Key Top Players Johnson & Johnson Private Limited (U.S), Pega Medical (U.S), General Electric Company (U.S), Abbott (U.S), Phoenix Medical Systems, Medtronic (Ireland), Siemens AG (Germany), Koninklijke Philips N.V. (Netherland) , Forecast To 2023

Pediatric medical devices are medical devices utilized for the management and treatment of infants and children below 18 years with some health issues. Majority of these medical devices are specially designed and manufactured for infants and children, but in some cases these devices are used for adult also.

Global Pediatric Medical Device Market is expected to grow at a CAGR of approximately 10.5% during the forecast period 2017-2023. The global pediatric medical devices market is growing immensely due to rising occurrence of disease among children, increasing child bearing age among women, high number of children with heart diseases, increasing growth in number of pediatric hospitals and clinics. Furthermore, initiatives by the government and regulatory organization are influencing the market growth. For example, FDA has taken initiatives like they are collaborating with the Institute of Medicine for the success of post-market surveillance of pediatric medical devices to enhance the development and availability of safe and effective pediatric medical devices. While there are few factors that hamper the growth of the market such as lack of significant biocompatibility and safety criteria for the medical devices have restrained the growth of market. Moreover, devices that can provide appropriate care to the pediatric patients is one of the other major restraint for the market. The market is forecasted to demonstrate a steady growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period 2017 – 2023.


Global Pediatric Medical Device Market - Competitive Analysis

Characterized by the presence of several well-established and small players, the global market of pediatric medical device appears to be highly competitive and fragmented. With well-established market in the North America and European region with major companies having their home in the regions and generating maximum market share. These companies have expanded their operating unit in various other emerging regions as well. Moreover the other small and medium scale players are generating revenue from local market.

Medtronic is a one of the global healthcare solutions provider company, involved in improving lives of individuals through its medical technologies, services, and solutions. Medtronic in January 2015, announced the acquisition of Covidien. With this acquisition the company will enhance its medical device product. Covidient includes various pediatric medical device such as Pediatric Collection Devices, Pediatric Urology Accessories, Pediatric Latex Foley Catheters and various others. These product will further enhance the revenue for Medtronic.

Furthermore in October 2016, Medtronic is the first company to got an approval for its suite of cardiac rhythm and heart failure devices, it leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI) machines. This development provides patients with Medtronic implantable cardioverter-defibrillators (ICDs), SureScan MR-conditional pacemakers, and cardiac resynchronization therapy-defibrillators (CRT-Ds) and leads access to MRI scans on any part of the body.


Global Pediatric Medical Device Market - Regional Analysis

The global market is segmented into the various regions including North America, Europe, Asia Pacific, and the Middle East & Africa.

America accounted for the largest market share for global pediatric medical device market. It covers two of the major regions namely North America and South America. North America is the largest market the growth of the market is attributed to increase in growth of children with chronic diseases among, growth in number of women conceiving at older age addiction of pregnant women to smoking and alcohol, and technology advance medical devices manufactured by major market players. Abbott, General Electric Company and Johnson & Johnson Private Limited are major market players in the U.S. and presence all around the global. 

According to American Academy of Pediatrics, percentage of children in U.S with chronic health conditions is growing and diseases like asthma and attention deficit hyperactivity disorder have taken a rise at a disproportionate rate among them. In South America, significant increase in chronic diseases among children, demand for technology advanced pediatric medical devices, awareness regarding birth defects and child health influence this market’s growth.

For More Details Please Visit @ Market Research Future
at No comments:

Syringe and Needle Market Profile | Trend and SWOT Analysis | Forecast To 2023

The global Syringe and Needle Market Research by SWOT Analysis, Share, Size, Segmentation, Emerging Trends, Future Outlook, Applications, Insights with North America, Europe, Asia Pacific and the Middle East & Africa Regional Analysis and Key Players Albert David Ltd, Covidien Plc, Smiths Medical, and Connecticut Hypodermics Inc., B. Braun Medical Inc., Terumo Corporation, Forecast To 2023

global Syringe and Needle Market is expected to grow at a CAGR of 5.5% and surpass its previous revenues over the forecast period of 2017–2023, as per a research report published by Market Research Future (MRFR). The syringe and needle market is growing primarily on account of a large pool of patients who augment the demand for needle and syringe. High prevalence of blood-borne diseases leads to a surge in the application of syringes and needles which fuels the market growth. The global geriatric population is increasing and contributing significantly to the market growth. This demographic is at high risk for chronic diseases, and the natural aging process weakens the body leading to increased overall medical visits.

Increased demand for hypodermic needles which prevent the risk of needle-stick injuries also aids the growth of the market. Implementation of vaccination programs for diseases such as hepatitis, polio, rubella, tetanus, etc., also induces demand for needles and syringes which help in market expansion. Increase in a number of injectable drugs approved by the FDA also propels the market for syringes and needles. However, the growth of the market might be hindered by the risk associated with re-use and sharing of needles and syringes. Reuse of needles exposes consumers to the risk of acquiring diseases such as HIV and hepatitis C which is a major setback and constrain to the market growth. Risk of needle stick injuries and availability of alternatives also hinders the growth of the market. The market growth might be threatened by the introduction of needleless alternatives to meet the demands of a minimally invasive medical procedures.


Regional Analysis

The key markets of the global syringes and needle market include North America, Europe, Asia Pacific and the Middle East & Africa. North America accounts for the majority share of the global market owing to the prevalence of chronic diseases in the region coupled with increased R&D activities which induce the demand of the market. Additionally, the presence of a large customer base in the region also propels the market growth. Europe is the second largest market owing to increased R&D spending by pharmaceuticals and biotechnology sector in the region. Presence of a developed healthcare sector also supports the market growth in the region. Asia Pacific is expected to be the fastest growing market over the forecast period. The growth in the region would be favored by the prevalence of chronic diseases in the region which escalates the need for treatment and growing research and development in the field of life sciences in the region.  The Middle East & Africa region is expected to exhibit the least growth over the forecast period due to less expenditure on healthcare and limited growth of the healthcare sector in the region.


Segmentation
The global syringes and needle market has been segmented based on type, therapeutic application, usability, and end-user. By type, the market has been segmented into Blood Collection, Intravenous, and Catheter. By therapeutic application, the market has been segmented into General Surgery and Diagnostic. By usability, the market has been segmented into disposable and reusable. By end user, the market has been segmented into Hospitals & Clinics and Home Care. 

For More Details Please Visit @ Market Research Future
at No comments:
Subscribe to: Posts (Atom)

Ultra-low Temperature Freezers Market Profile, Trends and Applications By 2027

  According to the MRFR reports, the global   ultra-low temperature freezers market   is projected to acquire a market size of approximately...